> Ǿ > ž  

					
  ű ǰ, ǰ ǰ : DOLOMXA, DOLOMXB  ۼ

					

					

HL 20-46

ǰ

 

ű ǰ, ǰ ǰ ˷帮 ῡ Ͻñ ٶϴ.

 

219. Ÿ ȯ

Olomax

DOLOMXA 1Tab Olmesartan 20mg, Amlodipine 5mg, Rosuvastatin 5mg() (219)

DOLOMXB 1Tab Olmesartan 20mg, Amlodipine 5mg, Rosuvastatin 10mg() (219)

[] Olmesartan : Angiotensin receptor antagonist. Amlodipine : Calcium Channel Blocker. Rosuvastatin : HMG-CoA reductase inhibitor.

[ȿ] ø޻縣ź޵ҹ/Ϸε : Ϸε Ǵ ø޻縣ź޵ҹ ܵ ϰ ʴ ¼ ġ. μٽŸƾ : ߼ ݷ׷, ߼ ̻Ÿ, ȯ 輺 .

[] 1 1ȸ 1, Ļ Բ ð .

[] , αٰŸ, 󺹺, , , ʺ, ռ , Ź̸ , ALTAST , , , , ˷⼺ , ħ, ħ, , ƻ.

[ݱ] , Ӻ, Ӻ, , , û Ʈƹ̳ , ġ 3踦 ʰϴ ûƮƹ̳ ϴ Ȱ ȯ, , ź, żջ, 索̳ - ֿ ˸Ű , 뵿, , ٺ, ũν , ٺȾ ڴ 40mg ݱ. ҳ.

[] ü Ǵ , Ȯ, ⼺ 󵿸, ɺ, ̽, , Į, ڿ ټ, ȯ շ, ٺȾ , ġ Ư °̳ õ ٸ ʴ ߻, CKġ ġ 5 ̻ Ȥ ȣҽ, ٺ̳ Ⱦ ź ȭ Ͻϴ ޼ , Ǻ기 ü, ũν, ƾ, azole , protease , macrolide ׻ . 18 ̸ Ҿ.

[Ӻ] Ӻαݱ 1, Olmesartan(FDA D), Amlodipine(FDA C), Rosuvastatin(FDA X)

 

 

Sucroferric oxyhydroxide

DSUFE2.5G 2,500mg/Tab Velphoro chew(Ͽ콺) (219)

[] ö ΰ λ꿰 üܷ Ͽ λ꿰 Ǵ .

[ȿ] Ǵ ް ִ ȯ û .

[] ʱ 뷮 : 1 3(öμ 1,500 mg), Ļ Բ 1 þ .

: û ġ 1 1(öμ 500 mg) 2~4 Ǵ . Max. 6Tab/day(öμ 3,000 mg).

[] , , , , , ȭҷ, , â, ġ , .

[ݱ] ࿡ ȯ, Ÿ ö, ҳ.

[] , Ǵ ̷, , . Ӻ, . 18 ̸ Ҿ. 45.

[Ӻ] FDA B

 

 

232. ȭ˾

Rabeprazole sodium

DRBP5 5mg/Tab Pariet() (232)

[] Proton pump inhibitor ҿ Į̿ Ƶ3λ(H+, K+ -ATPase)ȿҸ Ͽ к .

[ȿ] ˾ ŷ ִ ȯڿ ־, 1 100mg 뷮 ƽǸ ˾ .

[] : 1 1ȸ 5mg.

[] , , , , , , ظ, , , εο, , ε巯, ġ , , , , , .

[ݱ] Ǵ ̴̹ ι, Ÿڳ Ǵ Ǻ ȯ, Ӻ .

[] , , ๰ ι շ. Ҿ. мҰ. (Է ).

[Ӻ] Ӻαݱ 2, FDA C.

[] ݱ : Ÿ ĸ 150mg, Ÿ ĸ 200mg.

 

 

235. ,

Akynzeo

DAKYN 1Tab Netupitant 300mg, Palonosetron 0.5mg(HK̳뿣) (235)

[] Netupitant : NK-1 receptor antagonist . Palonosetron : 5-HT3 antagonist θ .

[ȿ] ߵ- ߼ ׾ ȭп ʱ ݺ ġῡ ߵǴ ޼ .

[] ȭп 1ð 1ĸ . Ÿ ϴ 汸 Ÿ 뷮 50 % . ° Ű ̿ .

[] , , Ƿ, ȣ߱, , Ŀ尨, Ҹ, , , 1 , ɱ, , , , , , ȭҷ, â, , Ż, ε , , Ʈƹ̳, û ALP , û ũƼ , QT .

[ݱ] ȯ, Ӻ, ҳ.

[] Ÿ 5-HT3 ü ι, , Ʊ޼ ¡, Ÿ SSRIs, SNRIs , QT , QT Ǵ ɼ ִ, , CYP3A4 ַ ǰ ġ ๰(Ŭν, ŸũѸ, ÷Ѹ, ̺Ѹ, Ÿ, 𿡸Ÿ, Ÿ, Ÿ ׸ ϵ ) , CYP3A4 ȭп(Ź, ̸ĭ ) , ʿ ȯ, ̳ ῡ ι ִ ȯ. 75 ̻, 18 ̸ Ҿ. , , Ƿ ۱. мҰ.

[Ӻ] FDA B.

 

 

311. Ÿ A D

Calcitriol

DVITCCT1J 1mcg/mL/Amp Neobon(˺) (311)

[] Ȱ ŸD3μ, Į Ű 忡 Į , ۿ Ͽ Į 󵵸 ̰, λ PTH ȣ 󵵸 .

[ȿ] ȯ Į . µ ΰȣġ ۿ ż .

[] ʱ 뷮 : 3ȸ, 0.5mcg(0.01mcg/kg) IV bolus. ˻ġ, ӻ 2~4 0.25~0.5mcg . ȯ : 3ȸ, 0.5~3.0mcg (0.01~0.05mcg/kg) IV bolus. ī͸ .

[] ι, ŸD ߵ(, ٰ, , , , , ݼӼ , Ŀ, , ΰ, , , Ҹ, ո, , Ҿ, , ɰ, ɹ漼, , , ASTALT , BUN , , ).

[ݱ] ȯ, Į ȯ Ǵ Ÿ D İ ִ ȯ.

[] Į ʿ. Į . ȯڴ ˷̴ λ . ֱ û Į, , ׳׽, ALP 󵵸 ͸ 24ð Į . Ӻ, .

[Ӻ] Ӻαݱ 2, FDA C.

[] ݱ : 0.5mcg, ö 5mcg/ml.

 

 

Ziv-aflibercept

DC-ZAFBC100J 100mg/4mL/Vial Zaltrap(ǾƺƼ) (421)

DC-ZAFBC200J 200mg/8mL/Vial Zaltrap(ǾƺƼ) (421)

[] ǥȭ , Ư VEGF (VEGF-A, ¹ݼ(PIGF), VEGF- B) ģȭ Ͽ Ǽ (VEGF) θ .

[ȿ] ̸ĭ 5-FU ⺻ ϴ ȭп(FOLFIRI) Ͽ, 츮öƾ ϴ ȭп ġῡ ׼̰ų ̼ ġ.

[] 2ָ 1ȸ. 1ȸ 4mg/kg FOLFIRI 1ð IV infusion. * : Ŀ Ǵ 5 % 0.6~8 mg/ml ǵ .

[] , ȣ߱ǰ, Ŀ, ü߰, , , , ȣ, , ߼, , , , 󺹺, ASTALT, ı, ܹ鴢, .

[ݱ] ȯ, Ȱ/üֻ .

[] , õ, , , Ʒ, ڸ , , ܹ鴢, ȣ߱ ȣ߱Ҽ պ, Ż, , óġ պ, ĵκ ı, ECOG 2 ̻̰ų ȯ ִ , ɺ . Ӻ, . Ҿ. , (2-8C). ʴ (2~8) 24ð Ǵ 25 8ð .

[Ӻ] Ӻαݱ 2, FDA C.

 

 

ű

ڵ

Է

ǰ
(ȸ)

ǽ

DJPFND200

Pirfenidone 200mg/Tab

Fybro
()

Է ߰

2020.10.29

DJPFND600

Pirfenidone 600mg/Tab

Fybro
()

Է ߰

DJSNMCR200

1Tab Carbidopa 50mg (Carbidopa hydrate 54), Levodopa 200

Perkin CR
()

DSNMCR200 ü

DJ5ABMJ250

Human serum albumin
12.5g/250ml Btl

SK albumin Inj. 5%(SK ö)

D5ABMJ250ü

ǰ

ڵ

Է

ǰ
(ȸ)

ǽ

DSNMCR200

1Tab Carbidopa 50mg (Carbidopa hydrate 54), Levodopa 200

Sinemet CR()

ü:
DJSNMCR200

2020.10.29

D5ABMJ250

Human serum albumin 12.5g/250ml Btl 

Albumin greencross Inj.()

ü :
DJ5ABMJ250

ǰ(ȸ)

ڵ

Է

ǰ(ȸ)

ǽ

DAM-FOMPR14

1Bag(1448ml) glucose 13% 788ml, amino acid 10% 456ml, lipid 20% 204ml.

Foms TNA Peri Inj. 1448ml()

Yuhan Three Chamber Foms Peri Inj. ()

2020.10.29

 

 

2020. 10. 29.

 

ǰ ( 9561)